机构

• 上海药物研究所 [40]
• 海洋研究所 [2]
• 上海生物化学与细胞生... [2]
• 合肥物质科学研究院 [2]
• 上海神经科学研究所 [1]
• 心理研究所 [1]
• 更多

采集方式

• OAI收割 [49]
• iSwitch采集 [1]

内容类型

• 期刊论文 [49]
• 学位论文 [1]

发表日期

• 2023 [2]
• 2022 [2]
• 2021 [4]
• 2020 [2]
• 2019 [5]
• 2018 [9]
• 更多

学科主题

• Biochemist... [1]
• Cell Biolo... [1]
• Oncology; ... [1]

筛选

浏览/检索结果: 共50条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Functional evidence that FGFR regulates MAPK signaling in organizer specification in the gastropod mollusk Lottia peitaihoensis 期刊论文  OAI收割 MARINE LIFE SCIENCE & TECHNOLOGY, 2023, 页码: 12 作者:  Tan, Sujian;  Huan, Pin;  Liu, Baozhong   |  收藏  |  浏览/下载：8/0  |  提交时间：2023/11/30 FGF signaling  Organizer specification  BMP signaling gradient  DV patterning  Mollusk   Structural Optimization of Fibroblast Growth Factor Receptor Inhibitors for Treating Solid Tumors 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 66, 期号: 5, 页码: 3226-3249 作者:  Li, Chunpu;  Dai, Yang;  Kong, Xiangtai;  Wang, Bao;  Peng, Xia   |  收藏  |  浏览/下载：2/0  |  提交时间：2024/03/27 Repurposing of the FGFR inhibitor AZD4547 as a potent inhibitor of necroptosis by selectively targeting RIPK1 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2022 作者:  Wang, Zuo-wei;  Zou, Feng-ming;  Wang, Ao-li;  Yang, Jing;  Jin, Rui   |  收藏  |  浏览/下载：30/0  |  提交时间：2022/12/22 AZD4547  RIPK1  inhibitors  SIRS model  anti-necroptosis   F-18-FDG PET as an imaging biomarker for the response to FGFR-targeted therapy of cancer cells via FGFR-initiated mTOR/HK2 axis 期刊论文  OAI收割 THERANOSTICS, 2022, 卷号: 12, 期号: 14, 页码: 6395-6408 作者:  Jiang, Yuchen   |  收藏  |  浏览/下载：26/0  |  提交时间：2022/12/13 F-18-FDG  FGFR  Therapeutic Response  PET/CT  mTOR/HK2   Discovery of a novel DDRs kinase inhibitor XBLJ-13 for the treatment of idiopathic pulmonary fibrosis 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2021, 页码: 11 作者:  Dong, Ying;  Tang, Bi-xi;  Wang, Qi;  Zhou, Li-wei;  Li, Cong   |  收藏  |  浏览/下载：53/0  |  提交时间：2022/01/04 idiopathic pulmonary fibrosis  DDRs  kinase inhibitor  indazole derivatives  XBLJ-13  nintedanib  bleomycin-induced pulmonary fibrosismouse model   Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial 期刊论文  OAI收割 CLINICAL CANCER RESEARCH, 2021, 卷号: 27 作者:  Li, Dapeng;  Chi, Yihebali;  Chen, Xiaohong;  Ge, Minghua;  Zhang, Yuan   |  收藏  |  浏览/下载：40/0  |  提交时间：2021/08/31 Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyridazinone derivatives as covalent FGFR inhibitors 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2021, 卷号: 11, 期号: 3, 页码: 781-794 作者:  Wu, Xiaowei;  Dai, Mengdi;  Cui, Rongrong;  Wang, Yulan;  Li, Chunpu   |  收藏  |  浏览/下载：35/0  |  提交时间：2021/05/24 Tyrosine kinase  Covalent FGFR inhibitors  Virtual screening  Pyrazolo[3,4-d] pyridazinone  Structure-activity relationships  Antitumor efficacy   A pentapeptide enabled AL3810 liposome-based glioma-targeted therapy with immune opsonic effect attenuated 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2021, 卷号: 11, 期号: 1, 页码: 283-299 作者:  Li, Jinyang;  Lu, Jiasheng;  Guo, Haiyan;  Zhou, Jianfen;  Wang, Songli   |  收藏  |  浏览/下载：29/0  |  提交时间：2021/05/24 Liposome  mn  c(RGDyK)  Immune opsonization  Immunogenicity  Anti-glioma efficacy   DW14383 is an irreversible pan-FGFR inhibitor that suppresses FGFR-dependent tumor growth in vitro and in vivo 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 9 作者:  Dai, Meng-di;  Wang, Yue-liang;  Fan, Jun;  Dai, Yang;  Ji, Yin-chun   |  收藏  |  浏览/下载：66/0  |  提交时间：2021/05/24 receptor tyrosine kinase  FGFR inhibitor  DW14383  antitumor activity   Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models. 期刊论文  OAI收割 CANCER IMMUNOLOGY RESEARCH, 2020, 卷号: 8, 期号: 3, 页码: 70-70 作者:  Dai, Yang;  Ji, Yichun;  Shen, Yanyan;  Su, Yi;  Liu, Bo   |  收藏  |  浏览/下载：39/0  |  提交时间：2020/07/01